Aeirtec can provide preclinical compound testing design and conduct for

Lead Compound  Selection -  Profiling -  Immunogenicity

Aeirtec’s immune-inflammatory cellular pharmacology will examine your
compound action in cells from our healthy and diseased subjects; primary or
cell lines:

Lymphocytes (naïve and memory)  Dendritic Cells  Monocytes 
Macrophages  Osteoclasts  Neutrophils  Platelets  Synoviocytes  Chondrocytes

Human Immune and inflammatory cells provide you with the best cellular predictor
of compound action in the clinic. Human cells can be applied to examination
of compound efficacy, vaccine potential or immunogenicity (automated
fluorescence ELISPOT)

To discuss your preclinical requirements -  email: info@aeirtec.co.uk